Nektar Therapeutics SEC filings NKTR
Nektar Therapeutics has 1,000 filings in SEC EDGAR's recent list, going back to Aug 5, 2015. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 1, 2025 | — |
| CORRESP | Letter to the SEC | Mar 28, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 20, 2025 | — |
| DRSLTR | Filing | Mar 14, 2025 | — |
| DRS | Filing | Mar 14, 2025 | — |
| EFFECT | Filing | Jun 5, 2024 | — |
| CORRESP | Letter to the SEC | Jun 3, 2024 | — |
| UPLOAD | Letter from the SEC | May 31, 2024 | — |
| D | Filing | Mar 19, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 13, 2021 | — |
| CORRESP | Letter to the SEC | Nov 9, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2019 | — |
| CORRESP | Letter to the SEC | Dec 7, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2018 | — |
| CT ORDER | Filing | May 22, 2018 | — |
| D | Filing | Apr 3, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2018 | — |
| CORRESP | Letter to the SEC | Dec 27, 2017 | — |
| CT ORDER | Filing | Dec 19, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 14, 2017 | — |
| CORRESP | Letter to the SEC | Nov 20, 2017 | — |
| CORRESP | Letter to the SEC | Nov 15, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2017 | — |
| SD | Specialized disclosure (conflict minerals) | May 15, 2017 | — |
| CT ORDER | Filing | Dec 2, 2016 | — |
| CT ORDER | Filing | Oct 4, 2016 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NKTR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 906709
- Former names
- INHALE THERAPEUTIC SYSTEMS INC (until Jan 10, 2003); INHALE THERAPEUTIC SYSTEMS (until May 14, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.